Fanapt and Saphris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fanapt (iloperidone) and Saphris (asenapine maleate). Common drug interactions include insomnia among females and eating disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Fanapt and Saphris. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Fanapt?

Fanapt has active ingredients of iloperidone. It is often used in schizophrenia. eHealthMe is studying from 1,443 Fanapt users. Check the latest studies of Fanapt.

What is Saphris?

Saphris has active ingredients of asenapine maleate. It is often used in bipolar i disorder. eHealthMe is studying from 8,688 Saphris users. Check the latest studies of Saphris.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

41 people who take Fanapt and Saphris together, and have interactions are studied.

Fanapt and Saphris drug interactions.

What are the common drug interactions of Fanapt and Saphris, by gender? *:

female:

  1. Insomnia (sleeplessness)
  2. Weight increased
  3. Abnormal behaviour
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Heart rate increased
  7. Hunger
  8. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  9. Periodic limb movement disorder
  10. Sleep paralysis (waking up and unable to move or speak)

male:

  1. Eating disorder
  2. Acne (skin problems that cause pimples)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Tardive dyskinesia (a disorder that involves involuntary movements)
  5. Weight increased
  6. Acute respiratory failure
  7. Aggression
  8. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  9. Blood pressure systolic increased
  10. Coma (state of unconsciousness lasting more than six hours)

What are the common drug interactions of Fanapt and Saphris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Lactation disorder

20-29:

  1. Acne (skin problems that cause pimples)
  2. Eating disorder
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Toothache (tooth pain)
  5. Headache (pain in head)
  6. Aggression
  7. Insomnia (sleeplessness)
  8. Oral pain
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Influenza

30-39:

  1. Arthralgia (joint pain)
  2. Compulsive shopping
  3. Eating disorder
  4. Hospitalisation
  5. Nephrolithiasis (calculi in the kidneys)
  6. Weight increased
  7. Priapism (prolonged and painful erection that can last from several hours up to a few days)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)

40-49:

  1. Tardive dyskinesia (a disorder that involves involuntary movements)
  2. Neoplasm malignant (cancer tumour)
  3. Suicidal ideation
  4. Drug effect decreased
  5. Drug ineffective
  6. Dyskinesia (abnormality or impairment of voluntary movement)
  7. Dystonia (abnormal muscle tone)
  8. Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)
  9. Sexual dysfunction (difficulty experienced by an individual or a couple during any stage of a normal sexual activity)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Fatigue (feeling of tiredness)
  2. Heart rate increased
  3. Hunger
  4. Insomnia (sleeplessness)
  5. Merycism (a rare disease in which food is chewed, swallowed, and then returned to the mouth and chewed again)
  6. Muscle spasms (muscle contraction)
  7. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  8. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  9. Periodic limb movement disorder
  10. Pseudodementia (severe form of depression that results from a progressive brain disorder in which cognitive changes mimic those of dementia)

60+:

  1. Dizziness
  2. Somnolence (a state of near-sleep, a strong desire for sleep)

What are the existing conditions these people have? *

  1. Bipolar Disorder (mood disorder): 10 people, 24.39%
  2. Depression: 10 people, 24.39%
  3. Stress And Anxiety: 9 people, 21.95%
  4. Pain: 6 people, 14.63%
  5. Nausea (feeling of having an urge to vomit): 6 people, 14.63%
  6. Insomnia (sleeplessness): 6 people, 14.63%
  7. High Blood Cholesterol: 6 people, 14.63%
  8. Affective Disorder (mental disorder): 5 people, 12.20%
  9. Fever: 4 people, 9.76%
  10. Dyspnea (difficult or laboured breathing): 4 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take Fanapt and Saphris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fanapt and Saphris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fanapt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Saphris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fanapt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Saphris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on iloperidone and asenapine maleate (the active ingredients of Fanapt and Saphris, respectively), and Fanapt and Saphris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: